middle.news

IDT Australia Nearly Doubles Quarterly Revenue on Advanced Therapies Surge

7:03pm on Monday 2nd of June, 2025 AEST Pharmaceuticals
Read Story

IDT Australia Nearly Doubles Quarterly Revenue on Advanced Therapies Surge

7:03pm on Monday 2nd of June, 2025 AEST
Key Points
  • Q2FY25 revenue up 97.7% to $5.3 million, a record high
  • H1FY25 revenue expected to increase 82% to $10.5 million
  • Advanced Therapies revenue surged 1,765% to $2.5 million
  • New contracts worth $12.9 million secured in Q2FY25
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Idt Australia (ASX:IDT)
OPEN ARTICLE